Dr. Jose Joglar, the lead author of AHA’s new guidelines on diagnosing and treating irregular heartbeats, discusses how coffee affects heart health. What You Need to Know: New guidelines recently published in Circulation include material on healthy lifestyle, reducing risk, and…
Tag: Atrial Fibrillation
Heart attack significantly increases risk of other health conditions
Having a heart attack significantly increases the risk of developing other serious long-term health conditions, a major new study shows.
Posterior Wall Ablation Does Not Help Patients With Persistent Atrial Fibrillation
FOR IMMEDIATE RELEASE Contact: Ilana Nikravesh Mount Sinai Press Office 212-241-9200 [email protected] …
Heart of the Matter: Media Tipsheet From Smidt Heart Institute at Cedars-Sinai
Cardiologists and cardiac and vascular surgeons from the Smidt Heart Institute at Cedars-Sinai are available for interviews throughout February to discuss heart-related topics, including the latest advances in research and patient care.
Cedars-Sinai Uses AI to Identify People With Abnormal Heart Rhythms
Investigators from the Smidt Heart Institute at Cedars-Sinai found that an artificial intelligence (AI) algorithm can detect an abnormal heart rhythm in people not yet showing symptoms.
Cardiac Arrest: Hispanics, Latinos With Kidney Disease at High Risk
Hispanics and Latinos with chronic kidney disease are at significant risk for suffering from sudden cardiac arrest, according to a new study from the Smidt Heart Institute at Cedars-Sinai.
Half as many AF patients dying of heart attacks and strokes in the UK
Patients living with one of the UK’s most common heart rhythm conditions are 50% less likely to die from a heart attack or stroke than they were at the start of the millennium, new research has found.
Dissolving cardiac device monitors, treats heart disease
Nearly 700,000 people in the United States die from heart disease every year, and one-third of those deaths result from complications in the first weeks or months following a traumatic heart-related event. To help prevent those deaths, researchers at Northwestern and George Washington (GW) universities have developed a new device to monitor and treat heart disease and dysfunction in the days, weeks or months following such events.
Chula’s AICute Innovation – An Assessment Tool for Ischemic Stroke Risk to Reduce Disability and Death
A research team from the Faculty of Medicine and Faculty of Engineering, Chulalongkorn University has jointly developed AICute, an innovative program to assess the chances of stroke caused by heart disease (Ischemic Stroke), aimed at helping hospitals that lack cardiologists to enhance the effectiveness of stroke treatment, reduce congestion in hospitals and medical schools.
Heart Rhythm Disorders: What You Need to Know
Heart rhythm disorders like atrial fibrillation and sudden cardiac arrest have made headlines in recent months, prompting many to learn more about how the heart beats.
Gum infection linked to increased risk of heart arrhythmia
Periodontitis, a gum disease, can lead to a litany of dental issues from bad breath to bleeding and lost teeth.
Detection of left atrial mechanical dysfunction by measurement of left atrial reservoir strain improves stroke prediction in persons without a history of atrial fibrillation or stroke
A cohort study of more than 4,500 persons without a history of atrial fibrillation (AF) or stroke has found that measuring left atrial mechanical function can improve stroke prediction. The findings are published in Annals of Internal Medicine.
Screening for stroke risk can save lives and money
Atrial fibrillation is the greatest risk factor for stroke. Screening to detect atrial fibrillation in older people would not only increase the chance of preventing stroke, it would also save money for the healthcare system and society.
National study suggests it’s time to rethink how we treat atrial fibrillation
A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding light on how to more effectively treat atrial fibrillation (AF) – a common heart rhythm problem associated with increased risk of stroke and heart failure.
Cleveland Clinic Researchers Identify Diabetes Drug Metformin as Potential Atrial Fibrillation Treatment in Collaborative Research
Cleveland Clinic researchers have identified a common diabetes medication, metformin, as a possible treatment for atrial fibrillation.
The study, published in Cell Reports Medicine, built on ongoing collaborative Cleveland Clinic research to support further investigation into metformin as a drug repurposing candidate. Researchers used advanced computation and genetic sequencing to determine that metformin’s targets overlap significantly with genes dysregulated in atrial fibrillation.
AI-guided screening uses ECG data to detect a hidden risk factor for stroke
An AI-guided targeted screening strategy is effective in detecting new cases of atrial fibrillation that would not have come to attention in routine clinical care.
This strategy could reduce the number of undiagnosed cases of atrial fibrillation, and prevent stroke and death in millions of patients across the globe.
Early rhythm control associated with lower risk of cardiovascular complications compared to rate control in most AF patients
A cohort study of patients with atrial fibrillation (AF) and low risk for stroke has found that the use of early rhythm control therapy was associated with a lower risk of cardiovascular death, ischemic stroke, hospitalization for heart failure, or myocardial infarction compared to rate control therapy. The findings are published in Annals of Internal Medicine.
New drug molecule for treatment of atrial fibrillation
Scientists from the National University of Singapore (NUS) Department of Pharmacy have developed an improved pharmaceutical drug for the treatment of the most common heart rhythm disturbance – atrial fibrillation (AF). This technological breakthrough which could benefit millions of AF patients worldwide.
Few Patients Have Infected Heart Devices Removed Despite Lifesaving Benefits
Medicare patients whose implantable heart devices became infected were less likely to die from the complication if they had the hardware removed compared to patients who only received antibiotics, according to the largest study on the topic, led by the Duke Clinical Research Institute.
Human History and Migration of Disease: Study Tracks Spread of Young-Onset Heart Arrhythmia Across Continents
University of Utah Health scientists have documented the spread of a disease gene for the atrial fibrillation, a heart arrhythmia, across continents and over centuries. Understanding the geographic distribution and ancestry of disease could help identify people who are at risk today.
Heart rhythm disorders: Mayo Clinic Healthcare expert shares 5 things it’s important to know
World Heart Day is Sept. 29 – Heart rhythm disorders are one of the most common cardiac problems. Arrhythmias cause the heart to beat too fast, too slow, or irregularly. People can be born with them or develop them during their lives.
MedStar Health offers the first FDA approved treatment for long-standing, persistent atrial fibrillation
Two MedStar Health hospitals are now offering an FDA-approved treatment for patients who have had persistent atrial fibrillation for more than a year. The Hybrid AF™ Convergent Therapy is available both at MedStar Washington Hospital Center and MedStar Union Memorial Hospital in Baltimore.
Morristown Medical Center to Host 9th Annual Frontiers in Cardiovascular Disease Virtual Symposium
Atlantic Health System’s Morristown Medical Center, one of the nation’s leading heart hospitals, will host a virtual conference featuring some of the world’s most distinguished cardiovascular faculty, who will discuss the latest developments in heart disease. This program is cosponsored by the NJ Chapter of the American College of Cardiology.
The Medical Minute: Reducing stroke risk from AFib without blood thinners
To help prevent a stroke — a common and serious risk associated with AFib — patients are treated with blood thinners. But for some, the medication itself can be risky.
Edoxaban May Be Effective Treatment for Atrial Fibrillation After Transcatheter Aortic Valve Replacement
Mount Sinai study is first to compare this anticoagulant with the standard of care in large randomized clinical trial
New mutation raises risk for AFib, heart failure for people of color
A new mutation found in a gene associated with an increased risk of atrial fibrillation poses a significantly increased risk for heart failure in Black people.
The Valley Hospital is First Center in the World to Utilize WATCHMAN™ TruPlan™ CT Imaging Software
The Valley Hospital in Ridgewood, NJ, has become the first center in the world to utilize leading-edge imaging software designed to enhance the safety and efficacy of a Watchman implant procedure.
3D Electrocardiogram Might Detect Paroxysmal Atrial Fibrillation
Rockville, Md. (November 25, 2020)—Atrial fibrillation is the most frequent arrhythmia in both equine and human athletes. In this study, researchers investigated whether the arrhythmogenic substrate—the preexisting condition that causes arrhythmia—present between the episodes of paroxysmal atrial fibrillation (PAF) can…
Study: Vitamin D, Fish Oil Don’t Lower Atrial Fibrillation Risk
New research presented today at the American Heart Association Scientific Sessions suggests neither vitamin D nor the omega-3 fatty acids found in fish oil prevent the development of atrial fibrillation, a potentially serious heart rhythm disturbance.
Morristown Medical Center’s Dr. Stephen Winters Discusses What Everyone Should Know About Atrial Fibrillation
September is National Atrial Fibrillation Month, and Stephen L. Winters, MD, director of the Cardiac Rhythm Management Program, Gagnon Cardiovascular Institute, Atlantic Health System’s Morristown Medical Center, wants the public to know some surprising facts about this increasingly common heart condition.
Mount Sinai Cardiologists First on East Coast to Offer New Stroke Prevention Therapy for Heart Patients
New generation implant has improved safety and performance features for those with atrial fibrillation
CRF Will Hold Free Online Seminar on Heart Disease Warning Signs
The Cardiovascular Research Foundation (CRF) will hold a free online seminar, “Get Heart Smart,” on August 24 hosted by Drs. Nisha Jhalani and Ajay Kirtane, renowned academic cardiologists from NewYork-Presbyterian/Columbia University Irving Medical Center. The seminar, part of a series of “Mini Med Schools” conducted by the CRF Women’s Heart Health Initiative, will focus on common heart disease symptoms, when to talk to your doctor, and when to seek emergency care.
Critical Transition Theory Shows Flickering in Heart Before Atrial Fibrillation
Atrial fibrillation ranks among the most common heart conditions, and episodes are difficult to predict. Researchers have proposed a way to define cardiac state and have studied the dynamics before the cardiac rhythm changes from normal sinus to AF rhythm and vice versa. The work, appearing in Chaos and based on critical transition theory, looks to provide an early warning for those with paroxysmal atrial fibrillation with potential implications for future wearable devices.
Atomic Magnetometer Points to Better Picture of Heart Conductivity
Mapping the electrical conductivity of the heart would be a valuable tool in diagnosis and disease management, but doing so would require invasive procedures, which aren’t capable of directly mapping dielectric properties. Significant advances have recently been made that leverage atomic magnetometers to provide a direct picture of electric conductivity of biological tissues, and in Applied Physics Letters, new work in quantum sensors points to ways such technology could be used to examine the heart.
New evidence supports ablation for heart failure patients with atrial fibrillation
Only 1 in 13 everyday patients could have participated in a pivotal international clinical trial looking at the use of catheter ablation to treat atrial fibrillation (AFib) among people with heart failure. However, new Mayo Clinic research provides evidence supporting the benefit of ablation, and shows what the outcomes might be for everyday patients. The Mayo study will be published in Heart Rhythm Journal.
Ohio State First in U.S. to Use New Atrial Fibrillation Device
Cardiologists at The Ohio State University Wexner Medical Center are the first in the U.S. to test a new type of ablation technology for patients suffering from atrial fibrillation, a common type of irregular heartbeat.
Can obesity limit antiarrhythmic drug effectiveness?
A new study from researchers at the University of Illinois at Chicago is the first to show that some antiarrhythmic medications used to treat AFib are less effective in patients who are obese. The results of this study, which followed more than 300 patients in the UIC AFib Registry, are published in JAMA Cardiology.
Michigan hospital improves post-CABG outcomes, using proactive amiodarone protocol
A quality improvement project at Beaumont Hospital in Michigan resulted in a decreased incidence of postoperative atrial fibrillation and shorter mean lengths of stay. The results indicate that an amiodarone POAF prophylaxis protocol could significantly reduce costs, improve patient outcomes and increase the overall quality of care.
Skin-Cells-Turned-to-Heart-Cells Help Unravel Genetic Underpinnings of Cardiac Function
A small genetic study, published September 30, 2019 in Nature Genetics, identified a protein linked to many genetic variants that affect heart function. Researchers are expanding the model to other organ systems and at larger scales to create a broader understanding of genes and proteins involved.